Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

The pathogenesis of cutaneous fibrosis.

Liu B, Connolly MK.

Semin Cutan Med Surg. 1998 Mar;17(1):3-11. Review.

PMID:
9512100
2.

[Pathogenesis of skin scleroderma--literature review].

Wojas-Pelc A, Lipko-Godlewska S.

Przegl Lek. 2005;62(5):310-3. Review. Polish.

PMID:
16334538
3.

Molecular aspects of scleroderma.

Trojanowska M.

Front Biosci. 2002 Mar 1;7:d608-18. Review.

PMID:
11861221
4.

The pathophysiology of the fibrosis in scleroderma skin.

Fleischmajer R, Perlish JS.

Prog Clin Biol Res. 1984;154:381-404. No abstract available.

PMID:
6382305
5.

Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma.

Higashi-Kuwata N, Makino T, Inoue Y, Takeya M, Ihn H.

Exp Dermatol. 2009 Aug;18(8):727-9. doi: 10.1111/j.1600-0625.2008.00828.x. Epub 2009 Mar 3.

PMID:
19320738
6.

Role of cytokines and proteases in murine scleroderma.

Matsushita M, Yamamoto T, Yokozeki H.

J Med Dent Sci. 2008 Sep;55(3-4):215-25. Review.

PMID:
19697510
7.
8.
9.

Chemokines and chemokine receptors in scleroderma.

Yamamoto T.

Int Arch Allergy Immunol. 2006;140(4):345-56. Epub 2006 Jun 27. Review.

PMID:
16804319
10.
11.

Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis.

Chujo S, Shirasaki F, Kondo-Miyazaki M, Ikawa Y, Takehara K.

J Cell Physiol. 2009 Jul;220(1):189-95. doi: 10.1002/jcp.21750.

PMID:
19277979
12.

Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.

Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N.

Arthritis Rheum. 2004 Jan;50(1):216-26.

13.
14.

Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.

Shi-wen X, Pennington D, Holmes A, Leask A, Bradham D, Beauchamp JR, Fonseca C, du Bois RM, Martin GR, Black CM, Abraham DJ.

Exp Cell Res. 2000 Aug 25;259(1):213-24.

PMID:
10942593
16.

Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.

Bock O, Yu H, Zitron S, Bayat A, Ferguson MW, Mrowietz U.

Acta Derm Venereol. 2005;85(3):216-20.

17.

Epidemiology and pathogenesis of scleroderma.

Chen K, See A, Shumack S.

Australas J Dermatol. 2003 Feb;44(1):1-7; quiz 8-9. Review.

PMID:
12581091
18.

Potential roles of CCL2/monocyte chemoattractant protein-1 in the pathogenesis of cutaneous sclerosis.

Yamamoto T.

Clin Exp Rheumatol. 2003 May-Jun;21(3):369-75. Review.

PMID:
12846061
19.

Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse.

Ong VH, Evans LA, Shiwen X, Fisher IB, Rajkumar V, Abraham DJ, Black CM, Denton CP.

Arthritis Rheum. 2003 Jul;48(7):1979-91.

20.

Systemic and localized scleroderma.

Chung L, Lin J, Furst DE, Fiorentino D.

Clin Dermatol. 2006 Sep-Oct;24(5):374-92. Review.

PMID:
16966019

Supplemental Content

Support Center